Kiniksa Pharmaceuticals International (KNSA) News Today $38.12 -0.17 (-0.44%) Closing price 04:00 PM EasternExtended Trading$37.76 -0.36 (-0.96%) As of 06:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock KNSA Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock Rating Lowered by Wall Street ZenOctober 5 at 2:46 AM | americanbankingnews.comKiniksa Pharmaceuticals International (NASDAQ:KNSA) Rating Lowered to Buy at Wall Street ZenOctober 3, 2025 | marketbeat.comAMI Asset Management Corp Sells 34,547 Shares of Kiniksa Pharmaceuticals International, plc $KNSAOctober 2, 2025 | marketbeat.comKiniksa Pharmaceuticals International (NASDAQ:KNSA) COO Sells $1,609,860.00 in StockOctober 2, 2025 | insidertrades.comInsider Selling: Kiniksa Pharmaceuticals International (NASDAQ:KNSA) COO Sells 42,000 Shares of StockOctober 1, 2025 | marketbeat.comKiniksa Pharmaceuticals International (NASDAQ:KNSA) Earns Buy Rating from Analysts at TD CowenSeptember 30, 2025 | americanbankingnews.comWhat Analysts Are Saying About Kiniksa Pharmaceuticals StockSeptember 30, 2025 | benzinga.comKiniksa Pharmaceuticals International (NASDAQ:KNSA) Sets New 52-Week High - What's Next?September 29, 2025 | marketbeat.comKiniksa Pharmaceuticals International (NASDAQ:KNSA) Now Covered by TD CowenSeptember 29, 2025 | marketbeat.comVoya Investment Management LLC Buys 10,878 Shares of Kiniksa Pharmaceuticals International, plc $KNSASeptember 26, 2025 | marketbeat.comKiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock Price Expected to Rise, Wells Fargo & Company Analyst SaysSeptember 26, 2025 | americanbankingnews.comWells Fargo & Company Forecasts Strong Price Appreciation for Kiniksa Pharmaceuticals International (NASDAQ:KNSA) StockSeptember 25, 2025 | marketbeat.comPallas Capital Advisors LLC Buys New Shares in Kiniksa Pharmaceuticals International, plc $KNSASeptember 23, 2025 | marketbeat.comToth Financial Advisory Corp Makes New $296,000 Investment in Kiniksa Pharmaceuticals International, plc $KNSASeptember 22, 2025 | marketbeat.comStrs Ohio Purchases Shares of 26,800 Kiniksa Pharmaceuticals International, plc $KNSASeptember 21, 2025 | marketbeat.comGoldman Sachs Group Inc. Sells 54,859 Shares of Kiniksa Pharmaceuticals International, plc $KNSASeptember 19, 2025 | marketbeat.comKiniksa Pharmaceuticals International (NASDAQ:KNSA) COO Sells $597,944.00 in StockSeptember 18, 2025 | marketbeat.comInsider Selling: Kiniksa Pharmaceuticals International (NASDAQ:KNSA) COO Sells 16,400 Shares of StockSeptember 18, 2025 | insidertrades.comShort Interest in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Grows By 29.7%September 17, 2025 | marketbeat.comKiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Receives Consensus Rating of "Buy" from AnalystsSeptember 16, 2025 | marketbeat.comAcadian Asset Management LLC Grows Position in Kiniksa Pharmaceuticals International, plc $KNSASeptember 13, 2025 | marketbeat.comFred Alger Management LLC Purchases New Position in Kiniksa Pharmaceuticals International, plc $KNSASeptember 13, 2025 | marketbeat.comAQR Capital Management LLC Has $10.92 Million Position in Kiniksa Pharmaceuticals International, plc $KNSASeptember 13, 2025 | marketbeat.comKiniksa Pharmaceuticals International (NASDAQ:KNSA) Sets New 1-Year High - Should You Buy?September 11, 2025 | marketbeat.comKiniksa Pharmaceuticals International (NASDAQ:KNSA) Insider Sells $124,397.13 in StockSeptember 10, 2025 | marketbeat.comKiniksa Pharmaceuticals International (NASDAQ:KNSA) COO Sells $477,451.74 in StockSeptember 10, 2025 | marketbeat.comEben Tessari Sells 85,271 Shares of Kiniksa Pharmaceuticals International (NASDAQ:KNSA) StockSeptember 10, 2025 | marketbeat.comKiniksa Pharmaceuticals International (NASDAQ:KNSA) Insider Sells 3,523 SharesSeptember 9, 2025 | insidertrades.comKiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock Rating Upgraded by Wall Street ZenSeptember 9, 2025 | marketbeat.comKiniksa Pharmaceuticals International, plc $KNSA Shares Sold by American Century Companies Inc.September 8, 2025 | marketbeat.comGranahan Investment Management LLC Sells 101,216 Shares of Kiniksa Pharmaceuticals International, plc $KNSASeptember 7, 2025 | marketbeat.comCubist Systematic Strategies LLC Takes Position in Kiniksa Pharmaceuticals International, plc $KNSASeptember 7, 2025 | marketbeat.comPDT Partners LLC Trims Stock Position in Kiniksa Pharmaceuticals International, plc $KNSASeptember 6, 2025 | marketbeat.comInvesco Ltd. Has $744,000 Stock Position in Kiniksa Pharmaceuticals International, plc $KNSASeptember 6, 2025 | marketbeat.comKiniksa Pharmaceuticals International (NASDAQ:KNSA) CAO Michael Megna Sells 11,000 SharesSeptember 5, 2025 | marketbeat.comEben Tessari Sells 15,091 Shares of Kiniksa Pharmaceuticals International (NASDAQ:KNSA) StockSeptember 5, 2025 | marketbeat.comKiniksa Pharmaceuticals International (NASDAQ:KNSA) Sets New 12-Month High - What's Next?September 5, 2025 | marketbeat.comIeq Capital LLC Acquires Shares of 43,625 Kiniksa Pharmaceuticals International, plc $KNSASeptember 5, 2025 | marketbeat.comADAR1 Capital Management LLC Reduces Stock Holdings in Kiniksa Pharmaceuticals International, plc $KNSASeptember 4, 2025 | marketbeat.comVestal Point Capital LP Invests $3.77 Million in Kiniksa Pharmaceuticals International, plc $KNSASeptember 4, 2025 | marketbeat.comBirchview Capital LP Takes $666,000 Position in Kiniksa Pharmaceuticals International, plc $KNSASeptember 4, 2025 | marketbeat.comKiniksa Pharmaceuticals International (NASDAQ:KNSA) CAO Sells $383,240.00 in StockSeptember 4, 2025 | insidertrades.comKiniksa Pharmaceuticals International, Plc (KNSA) Presents At Citi's Biopharma Back To School Conference TranscriptSeptember 3, 2025 | seekingalpha.comBraidwell LP Sells 1,489,538 Shares of Kiniksa Pharmaceuticals International, plc $KNSASeptember 3, 2025 | marketbeat.comTrexquant Investment LP Has $5.25 Million Stake in Kiniksa Pharmaceuticals International, plc $KNSASeptember 3, 2025 | marketbeat.comWellington Management Group LLP Increases Stock Holdings in Kiniksa Pharmaceuticals International, plc $KNSASeptember 2, 2025 | marketbeat.comKodai Capital Management LP Takes $4.12 Million Position in Kiniksa Pharmaceuticals International, plc $KNSASeptember 1, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Purchases 42,353 Shares of Kiniksa Pharmaceuticals International, plc $KNSASeptember 1, 2025 | marketbeat.comKiniksa Pharmaceuticals International (NASDAQ:KNSA) Lowered to Buy Rating by Wall Street ZenSeptember 1, 2025 | marketbeat.com86,203 Shares in Kiniksa Pharmaceuticals International, plc $KNSA Acquired by Walleye Capital LLCAugust 31, 2025 | marketbeat.com Get Kiniksa Pharmaceuticals International News Delivered to You Automatically Sign up to receive the latest news and ratings for KNSA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. KNSA Media Mentions By Week KNSA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KNSA News Sentiment▼0.410.54▲Average Medical News Sentiment KNSA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KNSA Articles This Week▼66▲KNSA Articles Average Week Get the Latest News and Ratings for KNSA and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Kiniksa Pharmaceuticals International and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Roivant Sciences News QIAGEN News Elanco Animal Health News BridgeBio Pharma News Moderna News Verona Pharma PLC American Depositary Share News Revolution Medicines News Grifols News Rhythm Pharmaceuticals News Avidity Biosciences News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KNSA) was last updated on 10/7/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kiniksa Pharmaceuticals International, plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Kiniksa Pharmaceuticals International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
